Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

NVOH

Novo Nordisk A/S (B Shares) ADRhedged

Feb 13 • 04:00PM ET

26.33

+0.20 0.78 %

Financial • Exchange Traded Fund • USA • NYSE

Category	Global or ExUS Equities - Industry Sector	Asset Type	Equities (Stocks)	Tags	Europe	Return% 1Y	-44.23%	Total Holdings	2	Perf Week	3.32%
Sponsor	Precidian	ETF Type		Tags	single-asset	Return% 3Y	-	AUM	4.23M	Perf Month	-17.40%
Fund Family		Bond Type		Tags	NVO	Return% 5Y	-	NAV/sh		Perf Quarter	-5.24%
Index	-	Average Maturity		Tags	hedge-currency	Return% 10Y		52W High	54.13 -51.37%	Perf Half Y	-5.01%
Index Weighting		Commodity Type		Tags	-	Return% SI		52W Low	23.29 13.02%	Perf YTD	-4.05%
Active/Passive		Quant Type		Tags	-	Flows% 1M	17.77%	Volatility	4.54% 4.69%	Perf Year	-43.28%
Dividend TTM	0.65 (2.48%)	ESG Type		Tags	-	Flows% 3M	129.64%	ATR (14)	1.41	Perf 3Y	-
Dividend Ex-Date	Dec 16, 2025	Dividend Type		Sector/Theme		Flows% YTD	59.31%	RSI (14)	40.58	Perf 5Y	-
Dividend Gr. 3/5Y	- -	Structure Type		Region		Flows% 1Y		Beta	1.64	Perf 10Y	-
Expense	0.19%	Growth/Value		SMA20	-10.71%	Flows% 3Y		Rel Volume	0.31	Prev Close	26.12
Inverse/Leveraged		Market Cap		SMA50	-8.29%	Flows% 5Y		Avg Volume	6.79K	Price	26.33
IPO	Jan 07, 2025	Option/Short	No / Yes	SMA200	-16.89%	Trades		Volume	2,066	Change	0.78%

Novo Nordisk A/S (B Shares) ADRhedged seeks to provide investment results that correspond generally, before fees and expenses, to the total return of the ordinary shares of Novo Nordisk A/S (B Shares) in its local market. The series, under normal circumstances, invests at least 95% of its net assets in American Depositary Receipts ("ADRs") of the Novo Nordisk A/S (B Shares) (the "Company"). The series will not invest directly in the company. The fund is non-diversified.

open in yahoo | open in marketwatch | open in google

NVOH

Novo Nordisk A/S (B Shares) ADRhedged

Upgrade your FINVIZ experience